13 C-Methacetin Breath Test Predicts Survival in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.
Simon Johannes GairingRobert KuchenLukas MüllerAlper CankayaJan WeertsAkin KapucuSimon SachseCarolin ZimpelFabian StoehrMichael B PittonJens MittlerBeate Katharina StraubJens Uwe MarquardtJörn M SchattenbergChristian LabenzRoman KloecknerArndt WeinmannPeter Robert GalleMarcus-Alexander WörnsFriedrich FoersterPublished in: Clinical and translational gastroenterology (2022)
Baseline and longitudinal 13 C-MBT values predict survival of patients with HCC undergoing TACE. The relative change in 13 C-MBT values predicts short-term mortality and may assist in identifying patients who will not benefit from further TACE treatment.